Drug profile

The FDA adverse-event record for Neomycin Sulfate, Usp + Nystatin, Usp + Thiostrepton, Usp + Triamcinolone Acetonide, Usp

Name: Neomycin Sulfate, Usp + Nystatin, Usp + Thiostrepton, Usp + Triamcinolone Acetonide, Usp - FDA Animal Adverse Event Reports
Creator: PlainBreed
License: https://creativecommons.org/publicdomain/zero/1.0/

23 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Neomycin Sulfate, Usp + Nystatin, Usp + Thiostrepton, Usp + Triamcinolone Acetonide, Usp. See the species affected, top reactions, and outcomes below.

23
adverse-event reports: 4.3%
death-coded share: Dog
most-reported species: 14
Loss of hearing - top reaction

Compiled by PlainBreed Editorial, Pet Health Editorial Team

Verify with FDA CVM →

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

4.3%

Death Rate

Active Ingredients

Neomycin Sulfate, UspNystatin, UspThiostrepton, UspTriamcinolone Acetonide, Usp

Administration Routes

UnknownIntraocularOral

Species Affected

Dog 19

Cat 3

Human 1

Most Affected Breeds

Unknown 5

Retriever - Labrador 4

Terrier - Boston 2

Bulldog - French 1

Domestic Mediumhair 1

Poodle (unspecified) 1

Shepherd Dog - Belgian Malinois 1

Doberman Pinscher 1

Maine Coon 1

Shepherd Dog - German 1

Most Reported Reactions

Loss of hearing 14

Vomiting 2

Loose stool 2

Death 1

Blood in urine 1

Medication error 1

Eye irritation 1

Generalised skin reaction 1

Polydipsia 1

Scleritis 1

Cloudy eye (for Miosis, Mydriasis, Anisocoria, Nystagmus - see 'Neurological') 1

Swollen lymph node 1

Outcome Breakdown

Ongoing

13 (54.2%)

Outcome Unknown

8 (33.3%)

Recovered/Normal

2 (8.3%)

Died

1 (4.2%)

Neomycin Sulfate, Usp + Nystatin, Usp + Thiostrepton, Usp + Triamcinolone Acetonide, Usp Adverse Event Insights

23 reports name Neomycin Sulfate, Usp + Nystatin, Usp + Thiostrepton, Usp + Triamcinolone Acetonide, Usp; 1 recorded a death outcome (4.3% of reported events, not a population-level mortality rate). Active ingredients: Neomycin Sulfate, Usp, Nystatin, Usp, Thiostrepton, Usp, Triamcinolone Acetonide, Usp. Administration routes: Unknown, Intraocular, Oral.

By species: Dog (19 reports), Cat (3 reports), Human (1 reports). By breed: Unknown (5), Retriever - Labrador (4), Terrier - Boston (2).

Leading clinical signs: Loss of hearing (14), Vomiting (2), Loose stool (2), Death (1). Outcome, 24 coded reports: Ongoing leads at 54.2%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.